Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI study of duloxetine treatment and brain network mechanisms in persistent somatoform pain disorder
ChiCTR-RPC-17012990Phase 4Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of duloxetine in pain disorder (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Visual Analogue Pain Rating Scale, Medical Outcomes Study Pain Measurement and 6 more. Started Oct 2017; status: recruiting.
02
Drugs
duloxetine
03
Conditions
pain disorder
Beyond the preview
Go deeper on ChiCTR-RPC-17012990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RPC-17012990.